Tag Archives: bpt

1-29-2013 Watchlist


A nice start to the week as the market held it’s ground but ended the markets winning streak. The futures are red at the moment but not down too much. Seems all the dips are supported the last few weeks so not concerned about any pullbacks, as they are short lived. Quite a few earnings yesterday and this morning. VMW, BMC, STX all bombed and are down big, F beat but is down on europe concerns. HOG, LLY, and PFE beat and look good pre-market.


The plan today is to stick with yesterdays winners, as well as possibly adding some $SODA calls for a bounce. I will be watching $AMZN like a hawk, but will be hard pressed to buy any calls as they are so expensive. I have a feeling it will overshoot over $300, but the $310 weekly calls are 1.55!!!!! If the plan changes I will post in chat and twitter today.


CMG had price increase from BAC this morning, so continue to like for a $320+ break. LNKD moved nicely and will likely hold my entire position into tomorrow, where I will look to close some out before the close and FB earnings.


SHLD surprised me as I thought we had a few days to get in, and I really like her for next week. I was able to get some Feb 16th 52.50 calls @ .30 an they closed at .84. If not in, its possible you could overpay only to watch it pull back a bit, so be a bit careful for now.


Here are the analyst changes i like this morning:


Chipotle investor sentiment more positive, says BofA/Merrill

BofA/Merrill said Chipotle's pre-announcement a few weeks ago clarified near-term issues and has shifted sentiment positively, allowing investors to focus on long-term fundamentals. The firm expects long-term unit growth and metrics, new businesses, and aggressive buybacks to drive shares. The firm rates Chipotle a Buy with an increased price target of $350, up from $310.


Keryx Biopharmaceuticals price target raised to $11 from $3 at Oppenheimer

Oppenheimer increased its target on Keryx after the company reported stronger than expected data for its Phase III trial evaluating Zerenex for the treatment of hyperphosphatemia in dialysis patients. The firm believes that Zerenex is very attractive from a commercial perspective, and it reiterates an Outperform rating on the stock.


Seagate investment validates Fusion-io market opportunity, says Piper Jaffray

Piper Jaffray views Seagate's (STX) $40M investment in Virident as a validation of the overall market opportunity for Fusion-io (FIO). The firm says Virident is the only logical alternative to Fusion-io and that Seagate's investment likely increases the takeover premium Fusion-io will garner. Piper thinks Seagate's investment will not change the competitive dynamic in the space as Virident has already received investments from Intel (INTC), Cisco (CSCO), Micron (MU) and others. The firm keeps an Overweight rating on Fusion-io shares with a $33 price target.



Salesforce.com initiated with a Buy at Maxim

Target $200.


I will be sticking to the same holdings from yesterday which are SHLD 52.50 FEB calls - CMG 330/335 weekly calls - LNKD 130/135 weekly calls


Here are the strikes I am looking to add this morning on SODA :



Stock Ticker Call/Put Strike Expiration Closing Price Entry Price
SODA CALL $57.50 FEB 0.40 0.40
SODA CALL $60.00 FEB 0.25 0.15



I am still in a lot of positions to include BPT, SAM, SBUX, TZOO, and KERX.


LeeMalone will be doing another class on using Think or Swim and trading options. The class will be for gold members and above at 4:30 on Thursday. Registration link will be up later today!



Lets have a great day!!


- Jimmybob

1-17-2013 Watchlist


The market held ground another day and looks ready to break today with jobless claims coming out a few minutes ago at a 5 year low. Earnings continues to roll in with BAC and C reporting decent earnings this morning... both are down pre-market. EBAY reported another stellar quarter after hours, mostly from paypal again, and is trading up PM.

Blackrock beat big on both sides, raised it’s dividend, and added to its stock repurchase plan. The stock is up 4%+ pm and is trading over $230. The $230 calls on the watchlist from yesterday should be looking good.

We have Intel after the bell today, and Morgan Stanley tomorrow. Will cover the earnings plays for next week in the week ahead Sunday at 10:30pm est.


An interesting read on what the fed is doing to equities, which is what we have talked about for the past year: http://www.bloomberg.com/news/2013-01-17/fed-concerned-about-overheated-markets-amid-record-bond-buying.html


AAPL bounced out of the 400s in strong fashion yesterday and received some nice analyst comments today from Goldman and JP Morgan. Also a nice read in WSJ about AAPL becoming a value stock and not a growth stock: http://professional.wsj.com/article/SB10001424127887323783704578246173657545416.html?mod=WSJPRO_hps_MIDDLEFifthNews


Here are the analyst changes today:



VIVUS downgraded to Sell from Hold at Brean Capital

Brean Capital downgraded VIVUS citing rich valuation and lowered Qsymia estimates



Netflix price target raised to $102 from $65 at Piper Jaffray

Piper Jaffray raised its price target for Netflix (NFLX) shares citing increased confidence in the company's ability to maintain competitive differentiation. Piper believes Netflix continues to have the best overall movie/TV subscription streaming library, but says the gap has closed somewhat for high quality movie availability due to EPIX licensing its library to both Amazon (AMZN) and Redbox Instant (CSTR). Piper keeps a Neutral rating on Netflix despite raising its price target to $102.



Apple could report upside to quarter, says Goldman

Goldman believes Apple can report a "healthy" upside to Q1 consensus estimates, particularly on iPhone units and margins. The firm believes shares are factoring in a worse case scenario and that the report could start a recovery in shares. The firm's product shipment estimates are iPhones of 48.4M, iPads of 23.4M, Macs of 5.1M, and iPods of 12.3M. Shares are Buy rated with a $760 price target.



Apple price target lowered to $725 from $770 at JPMorgan

JPMorgan lowered its near-term earnings estimates for Apple citing weaker than expected iPad sales in the December quarter. The firm believes lower iPad shipments could limit share upside in the near-term, but says it remains comfortable with its iPhone estimates. JPMorgan lowered its price target for Apple shares to $725 from $770 while keeping an Overweight rating on the stock.


Netflix didn’t pan out yesterday as rumors of Eihorn short caused a sell-off but may recoup the losses today. SHLD looked very good yesterday and hopefully we get some continuation. Need SODA to break $50 today to have a chance on the 52.50s. Took a shot on more BPT 80 calls which may get some life today if it breaks 79(oil being up should help as well)


Here are some of the strikes i am looking at:



Stock Ticker Call/Put Strike Expiration Closing Price Entry Price
BPT CALL $80.00 weekly 0.10 0.10
CBS CALL $43.00 weekly 0.05 0.10
BLK CALL $240.00 weekly 0.20 0.15




Lets have a great day!


- Jimmybob